ABVC BioPharma Profit Margin

ABVC BioPharma (ABVC) currently reports a profit margin of 59.58% as of June 2026. That compares with -800.57% in the prior-year period — up 107.4% year over year. That is above the Industrials sector average of 4.71%. Use the charts on this page to explore ABVC BioPharma's profit margin history and peer comparisons.

ABVC BioPharma's profit margin increased from -800.57% to 59.58% — a 107.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ABVC BioPharma's profit margin of 59.58% is higher than the Industrials sector average of 4.71%. That is roughly 1166.3% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but ABVC BioPharma's current 59.58% should be judged against Industrials norms (sector average: 4.71%) and against ABVC's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 59.58%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Industrials average is 4.71%. From there, open related valuation or income-statement pages for ABVC BioPharma, and consider following ABVC for alerts when major investors trade the stock.